Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Summary Literature (2)
Literature for DOID 0080599: Coronavirus infectious disease


Xenbase Articles :
( Denotes literature images)
The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline., Carlson EC,Macsai M,Bertrand S,Bertrand D,Nau J, Int J Mol Sci. March 15, 2023; 24(6):1422-0067.
Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of K18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2., Ewart G,Bobardt M,Bentzen BH,Yan Y,Thomson A,Klumpp K,Becker S,Rosenkilde MM,Miller M,Gallay P, PLoS Pathog. August 1, 2023; 19(8):1553-7374.